News

Former Real Madrid striker Javier “Chicharito” Hernández has shared his thoughts on Real Madrid’s recent exit from the UEFA ...
US stocks edged higher on Monday as investors focused on tech's temporary reprieve from President Trump's tariffs. But on ...
That would imply about a 20% drop in oil prices from current levels, as West Texas Intermediate (CL=F) crude oil prices ... trial of its once-daily GLP-1 pill candidate, setting the company ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...
Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...